These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14686317)

  • 21. Firms fumble for grip on HIV.
    AIDS Policy Law; 2003 May; 18(10):2. PubMed ID: 12809092
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapies. The high cost of poverty.
    Cohen J
    Science; 2002 Jun; 296(5577):2324. PubMed ID: 12089424
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment. Antiretroviral adherence results in lower health care costs, study says.
    AIDS Policy Law; 2010 Feb; 25(3):1. PubMed ID: 20419883
    [No Abstract]   [Full Text] [Related]  

  • 24. A remedy beyond lower cost drugs.
    Zuniga JM
    IAPAC Mon; 2001 Sep; 7(9):267. PubMed ID: 11708270
    [No Abstract]   [Full Text] [Related]  

  • 25. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEPFAR claims gains in global fight against AIDS.
    AIDS Policy Law; 2007 May; 22(10):2. PubMed ID: 17619264
    [No Abstract]   [Full Text] [Related]  

  • 27. Access to affordable drugs hinges on competition. Study notes lowest prices in India, South Africa.
    AIDS Alert; 2004 Nov; 19(11):129-30. PubMed ID: 15562531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAP fund officials predict shortfall that threatens lives of HIV patients. Congress can fix funding shortage with a $90 million infusion.
    AIDS Alert; 1999 Sep; 14(9):97-101. PubMed ID: 15386844
    [No Abstract]   [Full Text] [Related]  

  • 29. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 30. Costs of eliminating HIV in South Africa have been underestimated.
    Wagner B; Blower S
    Lancet; 2010 Sep; 376(9745):953-4. PubMed ID: 20851250
    [No Abstract]   [Full Text] [Related]  

  • 31. Free retroviral drugs could save up to 1.7 million South Africans.
    Sidley P
    BMJ; 2003 Jul; 327(7408):184. PubMed ID: 12881256
    [No Abstract]   [Full Text] [Related]  

  • 32. Africa access news.
    James JS
    AIDS Treat News; 2001 Oct; (372):7-8. PubMed ID: 11702415
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiretroviral therapy in South Africa--can we do it?
    Bekker LG; Wood R
    S Afr Med J; 2002 Mar; 92(3):191-3. PubMed ID: 12040936
    [No Abstract]   [Full Text] [Related]  

  • 35. AIDS, HIV, antiretrovirals and Africa.
    Gazzard B
    J HIV Ther; 2006 Mar; 11(1):4-6. PubMed ID: 16706248
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV services threatened by cutbacks and drug costs.
    Tighe A
    Nurs Stand; 2008 Jan 9-15; 22(18):33. PubMed ID: 18240803
    [No Abstract]   [Full Text] [Related]  

  • 37. Khousalya Periaswamy. Interview by Bob Huff.
    Periaswamy K
    GMHC Treat Issues; 2004; 18(5-6):3-5. PubMed ID: 15359436
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost imposes barrier to HIV treatment in Missouri.
    AIDS Policy Law; 2005 Jul; 20(13):2. PubMed ID: 16044518
    [No Abstract]   [Full Text] [Related]  

  • 39. Despair and hope in rural South Africa: the story of the antiretroviral drugs that are changing lives.
    Greenall J
    AIDS; 2008 Oct; 22(16):F1-3. PubMed ID: 18832868
    [No Abstract]   [Full Text] [Related]  

  • 40. Africa access: moving fast, outcome uncertain.
    James JS
    AIDS Treat News; 2001 Feb; (360):4-8. PubMed ID: 12173567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.